Key result
Early analysis of copeptin, along with saturation, heart rate, and NEWS category, was identified as an independent predictive marker for admission from the ED (P=0.002).
Why the study?
Discharging versus admitting patients is a critical ED decision, motivating evaluation of how triage systems and specific biomarkers associate with admission decisions.
Does risk assessment using RETTS, NEWS, and biomarkers (copeptin, MR-proADM, MR-proANP) predict the decision to admit patients with chest pain and/or breathlessness from the emergency department?
Observational
Does risk assessment using RETTS, NEWS, and biomarkers (copeptin, MR-proADM, MR-proANP) predict the decision to admit patients with chest pain and/or breathlessness from the emergency department?
Early analysis of copeptin, along with vital signs and NEWS category, may serve as an independent predictive marker for hospital admission in emergency department patients with chest pain or breathlessness.
Answers are grounded in this paper and cite their sources.
Copeptin may aid ED admission decisions alongside NEWS; hypothesis-generating for integration into risk scores pending validation.
Background: One of the most critical decisions that emergency department (ED) physicians make is the discharge versus admission of patients. We aimed to study the association of the decision in the ED to admit patients with chest pain and/or breathlessness to a ward with risk assessment using the Rapid Emergency Triage and Treatment System (RETTS), the National Early Warning Score (NEWS), and plasma levels of the biomarkers copeptin, midregional proadrenomedulin (MR-proADM), and midregional proatrial natriuretic peptide (MR-proANP). Methods: Patients presenting at the ED with chest pain and/or breathlessness with less than one week onset were enrolled. Patients were triaged according to RETTS. NEWS was calculated from the vital signs retrospectively. Conclusions: saturation, heart rate, NEWS category, and copeptin. As an independent predictive marker for admission, early analysis of copeptin might be beneficial when improving patient pathways at the ED.
No takes yet. Share an insight, caveat, or question.
Davidson et al. (2022) conducted an observational in Chest pain and/or breathlessness. Risk assessment using RETTS, NEWS, and biomarkers (copeptin, MR-proADM, MR-proANP) was evaluated on Admission to a ward (p=0.002). Early analysis of copeptin, along with saturation, heart rate, and NEWS category, was identified as an independent predictive marker for admission from the ED (P=0.002).
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: